Summary for:
WYLE LABORATORIES, INC.
|
The exact name of the Foreign Corporation:
WYLE LABORATORIES, INC.
|
The name was changed from: WESS Investment Corp. on 02-24-1995
|
The fictitious name of: KBRWYLE was filed on 09-11-2020 and was abandoned on 11-18-2020
The fictitious name of: Wyle was filed on 10-19-2007
The fictitious name of: Wyle Laboratories was filed on 03-17-1995
|
Entity type:
Foreign Corporation
|
Identification Number: 000082504
|
|
Date of Qualification in Rhode Island:
12-22-1994
|
Effective Date:
12-22-1994
|
Date of Revocation Certificate:
07-29-2021
|
|
Organized under the laws of: State: DE Country: USA
|
The location of the Principal Office:
|
|
|
|
|
|
Address: |
970 W. 190TH STREET STE. 890 |
City or Town, State, Zip, Country: |
TORRANCE,
CA
90502
USA
|
The mailing address or specified office:
|
|
|
|
|
|
Address: |
|
City or Town, State, Zip, Country: |
|
Agent Resigned: N
|
|
Address Maintained:
Y
|
|
The name and address of the Registered Agent:
|
|
|
|
|
|
Name: |
CT CORPORATION SYSTEM |
Address: |
450 VETERANS MEMORIAL PARKWAY, SUITE 7A |
City or Town, State, Zip, Country: |
EAST PROVIDENCE,
RI
02914
USA
|
The Officers and Directors of the Corporation:
|
SECRETARY | ADAM KRAMER | 970 W. 190TH STREET, STE. 890 TORRANCE, CA 90502 USA |
VICE PRESIDENT | ANDREW ZIRKELBACH | 970 W. 190TH STREET, STE. 890 TORRANCE, CA 90502 USA |
PRESIDENT AND CEO | WILLIAM (BYRON) BRIGHT | 970 W. 190TH STREET, STE. 890 TORRANCE, CA 90502 USA |
VICE PRESIDENT & TREASURER | NATASHA FRAUSTO | 970 W. 190TH STREET, STE. 890 TORRANCE, CA 90502 USA |
DIRECTOR | EILEEN G. AKERSON | 970 W. 190TH STREET, STE. 890 TORRANCE, CA 90502 USA |
DIRECTOR | GENERAL LESTER L. LYLES | 970 W. 190TH STREET, STE. 890 TORRANCE, CA 90502 USA |
DIRECTOR | MARK SOPP | 970 W. 190TH STREET, STE. 890 TORRANCE, CA 90502 USA |
DIRECTOR | WILLIAM (BYRON) BRIGHT | 970 W. 190TH STREET, STE. 890 TORRANCE, CA 90502 USA |
|
The total number of shares and the par value, if any, of each class of stock which this business entity is authorized to issue:
|
Class of Stock |
Series |
Par value per share |
Total Authorized |
Total issued and outstanding |
No. of shares |
No. of shares |
|
|
|